Skip to main content
GenEmbryomics Limited (XGEN)
GenEmbryomics will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.75
Shares Offered
1,095,000
Deal Size
$5.20M

GenEmbryomics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Year Ending
 Current Jun '24 Jun '23
Market Capitalization
43--
Enterprise Value
44--
Debt / Equity Ratio
-0.74-0.74-1.15
Debt / EBITDA Ratio
-0.39-0.39-0.51
Debt / FCF Ratio
-0.61-0.61-0.58
Quick Ratio
0.090.091.00
Interest Coverage
-10.14-10.14-
Return on Equity (ROE)
206.23%206.23%226.14%
Return on Assets (ROA)
-1396.10%-1396.10%-346.24%
Return on Capital (ROIC)
719.17%719.17%-1544.76%
Return on Capital Employed (ROCE)
187.86%187.86%-1537.09%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).